4
Changes in Ownership
Actinium Pharmaceuticals, Inc. Filed Acc 0001213900-13-007392
Options or other derivatives
- President and CEO acquired 675,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
DAVE KAUSHIK J · President and CEO
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2013-12-16 | Grant or award : show line 1 in the form Options to purchase common stock | +675,000 | $6.70 | $4,522,500 | 675,000 | D |
Loading xslF345X03/f4121613dave_actinium.xml…